Search results
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 20 hours agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...
Pfizer's first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Morningstar· 1 day agoPfizer Inc. on Wednesday reported first-quarter profit and sales that beat analyst expectations and raised its full-year earnings guidance as cancer and heart-disease drugs ...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 2 days agoPfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug...
Pfizer Reportedly Plans D2C COVID and Migraine Drug Platform
PYMNTS.com· 22 hours agoPharmaceutical giant Pfizer is reportedly creating an online platform selling anti-COVID and...
Pfizer stock climbs as first quarter earnings, revenue come ahead of estimates By Investing.com
Investing.com· 1 day agoPfizer stock climbs as first quarter earnings, revenue come ahead of estimates
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 1 day agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
Pfizer: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 1 day agoNEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Wednesday reported first-quarter net income of $3.12 billion. The New York-based company said it had profit of 55 cents ...
Pfizer revenues drop due to lower COVID-related product demand By Proactive Investors
Investing.com· 1 day agoPfizer reported a diluted earnings per share of $0.55, with an adjusted figure of $0.82, reflecting...
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 2 days agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...
Pfizer Earnings Top Views; Boosts Full-Year Guidance
Morningstar· 1 day agoBy Rob Curran Pfizer posted first-quarter earnings and sales that topped Wall Street targets and boosted its full-year projections as sales of blood thinners and cancer drugs ...